Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Equity (2016 - 2025)

Vanda Pharmaceuticals' Return on Equity history spans 14 years, with the latest figure at 0.13% for Q2 2025.

  • For Q2 2025, Return on Equity fell 11.0% year-over-year to 0.13%; the TTM value through Jun 2025 reached 0.13%, down 11.0%, while the annual FY2025 figure was 0.51%, 47.0% down from the prior year.
  • Return on Equity for Q2 2025 was 0.13% at Vanda Pharmaceuticals, down from 0.08% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.07% in Q3 2021 and bottomed at 0.13% in Q2 2025.
  • The 5-year median for Return on Equity is 0.02% (2022), against an average of 0.01%.
  • The largest YoY upside for Return on Equity was 3bps in 2021 against a maximum downside of -21bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.07% in 2021, then plummeted by -82bps to 0.01% in 2022, then crashed by -61bps to 0.0% in 2023, then tumbled by -528bps to 0.02% in 2024, then tumbled by -567bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Return on Equity are 0.13% (Q2 2025), 0.08% (Q1 2025), and 0.02% (Q2 2024).